Cargando…
Barbigerone prevents scopolamine-induced memory impairment in rats by inhibiting oxidative stress and acetylcholinesterase levels
The current study was designed for the evaluation of barbigerone on memory loss. In this experimental study, 24 Wistar rats (n = 6) were used. Control rats and scopolamine (SCOP)-treated control group rats were orally administered with 3 ml of 0.5% sodium carboxymethyl cellulose (vehicle), whereas b...
Autores principales: | AlGhamdi, Shareefa A., Al-Abbasi, Fahad A., Alghamdi, Amira M., Omer, Asma B., Afzal, Obaid, Altamimi, Abdulmalik S. A., Alamri, Abdulaziz, Alzarea, Sami I., Almalki, Waleed Hassan, Kazmi, Imran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090886/ https://www.ncbi.nlm.nih.gov/pubmed/37063992 http://dx.doi.org/10.1098/rsos.230013 |
Ejemplares similares
-
Neuroprotective
Effect of Barbaloin on Streptozotocin-Induced
Cognitive Dysfunction in Rats via Inhibiting Cholinergic and Neuroinflammatory
Cytokines Pathway—TNF-α/IL-1β/IL-6/NF-κB
por: Omer, Asma B., et al.
Publicado: (2023) -
Protective effect of fustin against adjuvant-induced arthritis through the restoration of proinflammatory response and oxidative stress
por: Alshehri, Sultan, et al.
Publicado: (2023) -
Rosinidin inhibits NF-κB/ Nrf2/caspase-3 expression and restores neurotransmitter levels in rotenone-activated Parkinson's disease
por: Alghamdi, Amira M., et al.
Publicado: (2023) -
Barbigerone Potentially
Alleviates Rotenone-Activated
Parkinson’s Disease in a Rodent Model by Reducing Oxidative
Stress and Neuroinflammatory Cytokines
por: Alharthy, Khalid M., et al.
Publicado: (2023) -
Vaccine Formulation Strategies and Challenges Involved in RNA Delivery for Modulating Biomarkers of Cardiovascular Diseases: A Race from Laboratory to Market
por: Shaharyar, Md. Adil, et al.
Publicado: (2023)